We design affordable, safe and effective drugs to safeguard and empower the brain throughout all stages of life. Our aim is to improve quality of life and longevity. We are creating new approaches to treat mental and behavioral disorders, and to enhance cognitive function in healthy people.

R&D Focus

NLS-1 is active in the field of cognitive enhancement and neuro somatic therapies in particular. These disorders remain largely under-diagnosed and current therapies lack in safety and effectiveness:

Attentional Disorders (ADHD, ADD, Deficit of alertness)
Excessive Daytime Sleepiness (Narcolepsy, Hypersomnias)
Pervasive Developmental Disorders (ASD, Oligophrenia)
Iron Cerebral Insufficency (Neuro-Anemia Syndrome, RLS)
Cognitive Impairments (MCI, AD)
Synucleopathies (PD, LB)
Primary Insomnia (SOI)